CPRXCatalyst Pharmaceuticals, Inc.
31.49USD0.00%Mkt Cap: 3.85B $P/E: 18.2034d ago
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing medicines for patients living with rare diseases in the United States. It offers Firdapse for the tr…
Industry Peers
BiotechnologyKey Statistics
Company
Market Cap3.85B $
Enterprise Value3.10B $
Revenue (TTM)596.96M $
Gross Profit501.74M $
Net Income (TTM)214.33M $
Revenue/Share4.874 USD
Last Price31.49 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees182
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS14888U1016
Valuation
P/E (Trailing)18.20
P/E (Forward)9.90
PEG—
EV/EBITDA10.14
EV/Revenue5.19
P/S6.46
P/B3.80
EPS (TTM)1.73
EPS (Forward)3.48
52W Range
19.0592% of range32.56
52W High32.56 USD
52W Low19.05 USD
Profitability
Gross Margin85.19%
Oper. Margin49.02%
EBITDA Margin51.23%
Profit Margin36.39%
ROE22.46%
ROA19.41%
Growth
Revenue Growth5.60%
Earnings Growth11.10%
Cash Flow & Leverage
Operating CF208.67M $
CapEx (TTM)58.00K $
FCF Margin28.78%
FCF Yield4.46%
Net Debt-753.18M $
Net Debt/EBITDA-2.46
Balance Sheet
Debt/Equity0.00
Current Ratio7.10
Quick Ratio6.70
Book Value/Sh8.288 USD
Cash/Share6.176 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)31.67 USD
Upside (mean)+0.6%
Target Range31.50 USD – 32.00 USD
$31.50+0.6% to mean$32.00
# Analysts3
Ownership
Shares Out.122.42M
Float115.58M
Insiders5.57%
Institutions90.00%
Short Interest
Short Ratio4.1d
Short % Float6.78%
Short % Out.6.41%
Shares Short7.85M
Short (prev mo.)8.19M
Technical
SMA 5031.37 (+0.4%)
SMA 20025.90 (+21.6%)
Beta0.74
S&P 52W Chg18.16%
Avg Vol (30d)1.74M
Avg Vol (10d)2.60M
Technical Indicators
RSI (14)70.2
MACD0.1326
MACD Signal0.1779
MACD Hist.-0.0453
BB Upper31.54 USD
BB Middle31.46 USD
BB Lower31.38 USD
BB Width0.51%
ATR (14)0.0596 USD
Vol Ratio (20d)0.00x